title: [Adjuvant chemo-endocrine therapy for early breast cancer patients--review of the literature].
authors.affiliation: Department of Surgery, Keio University School of Medicine.
authors.forename: T
authors.initials: T
authors.lastname: Ikeda
authors.forename: S
authors.initials: S
authors.lastname: Masamura
authors.forename: T
authors.initials: T
authors.lastname: Hohjoh
authors.forename: M
authors.initials: M
authors.lastname: Kawaguchi
authors.forename: S
authors.initials: S
authors.lastname: Takayama
authors.forename: H
authors.initials: H
authors.lastname: Tokura
authors.forename: R
authors.initials: R
authors.lastname: Miyabe
authors.forename: M
authors.initials: M
authors.lastname: Kitajima
authors.forename: A
authors.initials: A
authors.lastname: Matsui
authors.forename: K
authors.initials: K
authors.lastname: Kikuchi
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D011292:Premedication; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D007987:Gonadotropin-Releasing Hormone; D015251:Epirubicin; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil